in which Sanofi and Novo Nordisk have eclipsed Lilly, a pioneer in the field. The list price of Basaglar will be $316.85 for a pack of five pens, 15% below the list price of Lantus. The companies ...

Americans with a prescription for Lantus-branded insulin, regardless of insurance status, can now get the life-saving drug for only $35. Healthcare company GoodRx announced Thursday a partnership ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

The French firm announced a $35 (£28) per month price cap on Lantus for those with private insurance. Sanofi's changes follow in the footsteps of other drugmakers, Eli Lilly and Novo Nordisk.

Pen injectors were introduced over 20 years ago to deliver liquid medication. They allow users to select a dose of medication and inject this via a needle connected to a small reservoir within the pen ...

Sanofi’s total diabetes franchise sales declined 3.8% to € 3.59 billion in the first half of the year, with Lantus revenues falling ... through a pen or a pump, how the glucose is measured ...

Sanofi's wide lineup of branded drugs and vaccines ... launches offsetting patent losses and deteriorating pricing for Lantus. Following a sharp patent cliff in 2013, Sanofi faces relatively ...

GoodRx said in a statement that it is working with Sanofi to offer U.S. insulin patients a coupon for to a 30-day supply of Lantus, an insulin glargine injection and Sanofi's most widely ...